Stem cell source an important factor, impacting ability to treat myocardial infarction

When adipose-derived stem cells (ASCs) and bone marrow-derived stem cells (BMSCs) obtained from a single 84 year-old male donor with ischemic coronary disease were transplanted to treat myocardial infarction in a rat model, researchers found that the ASCs preserved more cardiac function in the test rats while neither stem cell type induced myocardial angiogenesis. ASCs ameliorated heart failure following MI in the group receiving ASCs while the BMSC group showed no similar benefit.

Fuente : http://www.eurekalert.org/pub_releases/2013-02/ctc...